| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/13/2007 | CA2631713A1 Modulators of cdc2-like kinases (clks) and methods of use thereof |
| 09/12/2007 | EP1832598A2 Therapeutic treatment of androgen receptor driven conditions |
| 09/12/2007 | EP1832291A2 use of pyridoxal phosphate for the treatment of diabetes and related complications |
| 09/12/2007 | EP1832290A2 Compositions and methods for use in targeting vascular destruction |
| 09/12/2007 | EP1832286A1 Preventive or therapeutic agent for sleep disorder |
| 09/12/2007 | EP1830883A2 Methods for inhibiting a decline in learning and/or memory in animals |
| 09/12/2007 | EP1830856A2 Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems |
| 09/12/2007 | EP1830833A2 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 09/12/2007 | EP1830829A1 Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae |
| 09/12/2007 | EP1658093B1 Use of a mixture containing oxytocin and testosteron or estradiol for treating disturbances of psychosocial experiences and behaviour |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1519925B1 Oxazole derivatives and their use as insulin sensitizers |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1372615A4 Compounds and compositions for delivering active agents |
| 09/12/2007 | EP1368038B1 Medicament for the administration of amifostine and related compounds |
| 09/12/2007 | EP1351694B1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 09/12/2007 | EP1268305B1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/12/2007 | EP1212366B1 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 09/12/2007 | EP1206269A4 Compositions and methods for the treatment of skin disorders |
| 09/12/2007 | EP1197227B1 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 09/12/2007 | EP1154788B9 Method for indentifying compounds that modulate sister chromatid separation |
| 09/12/2007 | EP0993613B1 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma |
| 09/12/2007 | EP0842268B1 Methods and compositions for identifying morphogen analogs |
| 09/12/2007 | CN101035547A Use of compounds containing thiol groups as an efflux pump inhibitor |
| 09/12/2007 | CN101035540A Pharmaceutical combinations containing benzoxazine for treating respiratory diseases |
| 09/12/2007 | CN101032467A Superregulated long-cycled lipid emulsion carrying medicine reagent for mainline |
| 09/11/2007 | US7268227 Posh nucleic acids, polypeptides and related methods |
| 09/11/2007 | US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis |
| 09/11/2007 | US7268222 For use in therapeutic, diagnostic, and pharmacogenomic applications |
| 09/11/2007 | US7268219 May be used to promote lysis of the target cell by T cells in the immune system or to promote proliferation of specific T cell clones |
| 09/11/2007 | US7268205 Biocompatibility; biopolymers such as poly-4-hydroxybutyrate, poly-4-hydroxybutyrate-co-3-hydroxybutyrate, poly-4-hydroxybutyrate-co-2-hydroxybutyrate, and copolymers and blends; controlled degradation rate; grafting |
| 09/11/2007 | US7268164 Administering an amino carbonyl compound |
| 09/11/2007 | US7268155 Photosensitizer conjugates for pathogen targeting |
| 09/11/2007 | US7268141 Xanthine phosphodiesterase V inhibitors |
| 09/11/2007 | US7268112 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 09/11/2007 | US7268109 Method for reducing pain |
| 09/11/2007 | US7267977 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 09/11/2007 | US7267949 Composition comprising methylphenidate and another drug |
| 09/11/2007 | US7267830 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
| 09/11/2007 | US7267819 Composition comprising and method of using angiopoietin-like protein 3 Angptl3 |
| 09/11/2007 | US7267815 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | CA2429114C Treatment of premature ejaculation |
| 09/11/2007 | CA2397262C Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
| 09/11/2007 | CA2260889C Granulates of hexahydropyrazine derivatives which can be administered orally |
| 09/11/2007 | CA2251281C Drug composition with controlled drug release rate |
| 09/11/2007 | CA2193967C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 09/07/2007 | WO2007100795A2 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions |
| 09/07/2007 | WO2007100211A1 Sisp-1, a novel p53 target gene and use thereof |
| 09/07/2007 | WO2007100071A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 09/07/2007 | WO2007099869A1 Therapeutic and preventive agent for hcv |
| 09/07/2007 | WO2007099852A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor |
| 09/07/2007 | WO2007098868A1 Use of moxifloxacin in combination with cefixime for treatment of infectious diseases caused by gram-positive and gram-negative pathogens |
| 09/07/2007 | WO2007084857A3 Methods and compositions for treating cell proliferative disorders |
| 09/07/2007 | WO2007084290A3 Compositions of an anticonvulsant and psychotherapeutic and methods of using the same for reversing weight gain |
| 09/07/2007 | WO2007071721A3 Ginger extract for inhibiting human drug transporters |
| 09/07/2007 | WO2007071708A3 Ginger fraction for inhibiting human cyp enzymes |
| 09/07/2007 | WO2007045689A3 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions |
| 09/07/2007 | WO2007009539A3 Use of inhibitors of histone deacetylases in combination with nsaid for the therapy of cancer and/or inflammatory diseases |
| 09/07/2007 | WO2006131721A3 Topical ungual formulations |
| 09/07/2007 | CA2644933A1 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions |
| 09/07/2007 | CA2638943A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 09/06/2007 | US20070208179 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 09/06/2007 | US20070207977 Naphthalimide compositions and uses thereof |
| 09/06/2007 | US20070207970 Use Of L-Carnitine For The Treatment Of Cardiovascular Diseases |
| 09/06/2007 | US20070207964 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 09/06/2007 | US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis |
| 09/06/2007 | US20070207523 Mammalian t-type calcium channels |
| 09/06/2007 | US20070207462 Preventive/Remedy for Respiratory Diseases |
| 09/06/2007 | US20070207218 Combinations of vanadium with antidiabetics for glucose metabolism disorders |
| 09/06/2007 | US20070207205 Rapidly Disintegrating Taste-Masked Tablet |
| 09/06/2007 | US20070207163 Recombinant soluble Fc receptors |
| 09/06/2007 | US20070207161 Immunomodulating Compositions and uses Therefor |
| 09/06/2007 | US20070207160 Apoptosis inhibitors |
| 09/06/2007 | US20070207153 Therapeutic Agents For Inner Ear Disorders Containing An Il-6 Antagonist As An Active Ingredient |
| 09/06/2007 | US20070207148 Genes associated with obesity and methods for using the same |
| 09/06/2007 | US20070207143 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| 09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/06/2007 | US20070207138 S/O Type Pharmaceutical Preparation and Method for Producing the Same |
| 09/06/2007 | US20070207120 Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6 |
| 09/06/2007 | US20070207119 synergistic; Tumor necrosis factor related apoptosis inducing ligand and LAQ824 (N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide) Dacinostat, which augments Apo-2L/TRAIL-induced DISC (death inducing signaling complex) and apoptosis of human acute leukemia cells |
| 09/06/2007 | US20070207088 Anti-Inflammatory Analgesic Adhesive Patch |
| 09/05/2007 | EP1829876A1 Nitrogeneous tricyclic compound |
| 09/05/2007 | EP1829553A1 Vitamins within mixtures of omega fatty acids |
| 09/05/2007 | EP1829551A1 Modified heat shock protein-antigenic peptide complex |
| 09/05/2007 | EP1829550A2 Methods for treating an ischemic disorder and improving stroke outcome |
| 09/05/2007 | EP1829537A1 Composition for body fat reduction |
| 09/05/2007 | EP1829535A2 Tissue factor antagonists and methods of use thereof |
| 09/05/2007 | EP1828165A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 09/05/2007 | EP1827500A2 Pegylated liposomal doxorubicin in combination with ecteinescidin 743 |
| 09/05/2007 | EP1827496A2 Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound |
| 09/05/2007 | EP1827495A2 Painkilling association comprising a dihydroimidazopyrazine derivative |
| 09/05/2007 | EP1827451A1 Use of a cyclopentenone prostaglandin for delaying for the onset and/or preventing the continuation of labour |
| 09/05/2007 | EP1827448A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors |
| 09/05/2007 | EP1827410A2 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 09/05/2007 | EP1628658A4 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof |
| 09/05/2007 | EP1545564B1 Combination preparation of hyaluronic acid and lidocaine and the use thereof |
| 09/05/2007 | EP1539802B1 Novel kcnq polypeptides and their uses in the diagnosis of mental disorders |
| 09/05/2007 | EP1505967A4 Method for treating obesity |